| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.945 | 19.160 | 28.722 | 24.070 | 17.321 | 9.609 |
| Total Income - EUR | - | - | - | - | 3.945 | 19.160 | 28.722 | 24.116 | 17.322 | 10.386 |
| Total Expenses - EUR | - | - | - | - | 126 | 8.967 | 10.841 | 10.559 | 9.635 | 5.257 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.819 | 10.193 | 17.880 | 13.557 | 7.687 | 5.129 |
| Net Profit/Loss - EUR | - | - | - | - | 3.701 | 9.660 | 17.036 | 12.849 | 6.167 | 4.039 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Anesofmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 155 | 14.174 | 9.365 | 5.755 | 895 | 172 |
| Current Assets | - | - | - | - | 3.769 | 7.193 | 16.670 | 19.176 | 10.918 | 7.247 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.248 | 2.332 | 2.794 | 11.305 | 7.859 | 3.775 |
| Cash | - | - | - | - | 2.522 | 4.861 | 13.876 | 7.870 | 3.060 | 3.473 |
| Shareholders Funds | - | - | - | - | 3.743 | 9.710 | 17.085 | 12.898 | 6.215 | 4.087 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 182 | 11.658 | 8.950 | 10.070 | 3.641 | 2.163 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 1.963 | 1.957 | 1.169 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anesofmed S.r.l.